Literature DB >> 27528958

Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre.

D K Lewis1, Rph Peters1, M J Schijffelen1, Grf Joaki2, A L Walsh3, J G Kublin4, J Kumwenda1, S Kampondeni1, M E Molyneux5, E E Zijlstra1.   

Abstract

The aims of the study were to measure the prevalence and outcome of mycobacteraemia in febrile hospitalised adults; to determine what proportion could be identified using routine methods; to assess clinical indicators of mycobacteraemia and the usefulness of a diagnostic trial of anti-TB treatment. We prospectively examined adults with fever or a history of fever admitted to adult medical wards of QECH, Blantyre. All had blood cultured for bacteria and mycobacteria, chest x-ray and sputum smears. M. tuberculosis was the commonest blood isolate, affecting 57 of 344 patients (17%). In 44 (77%) patients with mycobacteraemia, TB was identified using routine investigations; in only 6 (11%) it was not suspected. Strong clinical indicators of mycobacteraemia were anaemia, HIV seropositivity, cough, chronic fever, and a clinical diagnosis of AIDS on the day of admission. Of nine patients selected for a therapeutic trial of TB treatment, six had mycobacteraemia, of whom five died during the trial. Mortality on short course chemotherapy on the TB ward after one month, was similar whether patients had mycobacteramia (21%) or not (32%). TB can be identified with routine methods in most patients with mycobacteraemia. If treated, mycobacteraemia has as good an early outcome as TB without mycobacteraemia. Strengthening of basic facilities is likely to improve detection and treatment of mycobacterial disease.

Entities:  

Year:  2003        PMID: 27528958      PMCID: PMC3345446          DOI: 10.4314/mmj.v15i2.10778

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  23 in total

1.  Unrecognised Mycobacterium tuberculosis.

Authors:  A D Harries
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

2.  Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.

Authors:  A D Harries; N J Hargreaves; J Kumwenda; J H Kwanjana; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

3.  Acute generalized miliary tuberculosis in adults.

Authors:  C B CHAPMAN; C M WHORTON
Journal:  N Engl J Med       Date:  1946-08-22       Impact factor: 91.245

4.  Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi.

Authors:  A D Harries; D S Nyangulu; C Kang'ombe; D Ndalama; J R Glynn; H Banda; J J Wirima; F M Salaniponi; G Liomba; D Maher; P Nunn
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 May-Jun       Impact factor: 2.184

5.  Six cases of Mycobacterium tuberculosis bacteremia.

Authors:  P F Barnes; C Arevalo
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

6.  Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.

Authors:  G Maartens; P A Willcox; S R Benatar
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

7.  Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi.

Authors:  A D Harries; T E Nyirenda; A Banerjee; M J Boeree; F M Salaniponi
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jul-Aug       Impact factor: 2.184

8.  A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy.

Authors:  L K Archibald; L C McDonald; O Nwanyanwu; P Kazembe; H Dobbie; J Tokars; L B Reller; W R Jarvis
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

9.  Mycobacteremia in patients with the acquired immunodeficiency syndrome.

Authors:  B Grinsztejn; F C Fandinho; V G Veloso; E C João; M C Lourenço; S A Nogueira; L S Fonseca; E Werneck-Barroso
Journal:  Arch Intern Med       Date:  1997-11-10

10.  Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.

Authors:  C F Gilks; R J Brindle; C Mwachari; B Batchelor; J Bwayo; J Kimari; R D Arbeit; C F von Reyn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-02-01
View more
  1 in total

1.  Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.

Authors:  J C Hoogendoorn; L Ranoto; N Muditambi; J Railton; M Maswanganyi; H E Struthers; J A McIntyre; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-07-27       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.